Physician profile
Christopher Hubbard
NPI 1831182435
$6,047.39
in general payments reported to CMS, 2019-2025
30 companies · $362 in 2025
The $362 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $637 · 2021: $1,349 · 2022: $641 · 2023: $2,212 · 2024: $368 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,813 · Travel and Lodging: $1,129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,812.66 |
| Travel and Lodging | $1,128.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,623.96 | 2019-2025 | Variax, Anchorage, Prophecy |
| Alpha Orthopedic Systems | $788.19 | 2021-2023 | |
| Smith+Nephew, INC. | $709.33 | 2019-2025 | Grafix Pl, Stravix, Oasis Micro |
| Arthrex, INC. | $462.48 | 2023 | |
| Misonix INC | $306.23 | 2019-2020 | |
| Depuy Synthes Sales INC. | $153.42 | 2021-2025 | Motoband, Minibunion, Na |
| Paratek Pharmaceuticals, INC. | $144.02 | 2022-2023 | Nuzyra |
| Angiodynamics, INC. | $129.18 | 2022 | |
| Bioventus LLC | $114.04 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Horizon Therapeutics Plc | $87.48 | 2019-2021 | |
| Organogenesis INC. | $65.95 | 2019-2024 | |
| Averitas Pharma INC. | $45.61 | 2024 | Qutenza |
| Abbvie INC. | $40.07 | 2021-2023 | |
| Kerecis Limited | $36.18 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Blue Surgical LLC | $33.38 | 2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $32.39 | 2022-2024 | Senza |
| Medtronic Vascular, INC. | $32.28 | 2020 | |
| Acumed LLC | $31.06 | 2022 | |
| Celularity INC. | $26.00 | 2019 | |
| Acera Surgical, INC. | $25.20 | 2021 | |
| Convatec INC. | $22.97 | 2024 | |
| Paragon 28, INC. | $20.38 | 2021 | |
| Bone Support INC. | $19.80 | 2022 | |
| Sanara Medtech INC. | $17.38 | 2021 | |
| Nabriva Therapeutics, Plc | $16.06 | 2022 | |
| Allergan, INC. | $14.81 | 2020 | |
| Zimmer Biomet Holdings, INC. | $14.42 | 2021 | |
| Orthofix Medical, INC. | $11.80 | 2021 | |
| Zyla Life Sciences, INC. | $11.70 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $11.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hubbard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.